Progression-free survival as a potential surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma (GUIDANCE008).

Saved in:
Bibliographic Details
Title: Progression-free survival as a potential surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma (GUIDANCE008).
Authors: Wu JW; Infectious Disease Laboratory, Guangxi AlDs Clinical Treatment Center (Nanning), The Fourth People's Hospital of Nanning, Chang Gang Rd ErLi 1, Nanning, 530023, China., Yang DL; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, He Di Rd 71, Nanning, 530021, China., Chen SC; Department of Hepatobiliary Surgery, Wuzhou People's Hospital, Wuzhou, 543001, China., Li MJ; Department of Hepatobiliary Pancreatic Surgery, Guilin People's Hospital, Guilin, 542001, China., Liang YR; Department of Hepatobiliary and Pancreatic Surgery, First People's Hospital of Qinzhou, Qinzhou, 535000, China., Wang XY; Department of Hepatobiliary and Pancreatic Surgery, Second Affiliated Hospital of Guilin Medical University, Guilin, 541199, China., Yao HB; Department of Hepatobiliary and Pancreatic Surgery, Second Affiliated Hospital of Guilin Medical University, Guilin, 541199, China., Liu J; Department of Hepatobiliary Pancreatic Surgery, Guilin People's Hospital, Guilin, 542001, China., Wu PS; Department of Hepatobiliary and Pancreatic Surgery, First People's Hospital of Qinzhou, Qinzhou, 535000, China., Peng N; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China., Nong JL; Department of Hepatobiliary Surgery, Hengzhou City People's Hospital, Hengzhou, 530300, China., Yu YQ; Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, 541002, China., Ye L; Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, 541002, China., Su Z; Department of Hepatobiliary Pancreatic Surgery, First People's Hospital of Nanning, Nanning, 530016, China., Qin C; Department of Hepatobiliary Surgery, Liuzhou People's Hospital, Liuzhou, 545006, China., Chen K; Department of General Surgery, Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, China., Yan YH; Department of General Surgery, Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, China., Zeng FJ; Department of Hepatobiliary Surgery, Wuzhou Red Cross Hospital, Wuzhou, 543002, China., Liu SP; Department of Hepatobiliary and Pancreatic Surgery, Eighth Affiliated Hospital of the Guangxi Medical University, Guigang, 537100, China., Wu MS; Department of Oncology, People's Hospital of Beiliu, Beiliu, 537400, China., Yang FQ; Department of Hepatobiliary and Pancreatic Surgery, First People's Hospital of Yulin, Yulin, 537800, China., Lai YC; Department of Hepatobiliary Gland Surgery, Beihai People's Hospital, Beihai, 536000, China., Dong XF; Department of Hepatobiliary, Pancreatic and Spleen Surgery, People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, 530021, China., Zhong TM; Hepatobiliary Surgery Department, Baise People's Hospital, Baise, 533000, China., Pang QQ; Department of Oncology, Liuzhou Workers Hospital, Liuzhou, 545005, China., Li FX; Department of Hepatobiliary, Pancreatic and Spleen Surgery, People's Hospital of Hezhou, Hezhou, 532800, China., Liu AQ; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, He Di Rd 71, Nanning, 530021, China., Ma L; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, He Di Rd 71, Nanning, 530021, China., Zhong JH; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, He Di Rd 71, Nanning, 530021, China. zhongjianhong@gxmu.edu.cn., Cen P; Infectious Disease Laboratory, Guangxi AlDs Clinical Treatment Center (Nanning), The Fourth People's Hospital of Nanning, Chang Gang Rd ErLi 1, Nanning, 530023, China. cenping877@163.com.
Corporate Authors: GUIDANCE investigators
Source: Scientific reports [Sci Rep] 2026 Jun 03. Date of Electronic Publication: 2026 Jun 03.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2045-2322
DOI:10.1038/s41598-026-53344-3